Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06833554

The Role of Breast Milk Neutrophils From Mothers With Metabolic Diseases After Nutritional Intervention. Impact on Infant Development and Response to Pulmonary Infections

This project aims at identifying variations in breast milk neutrophils among lactating mothers with gestational diabetes or obesity (objective 1), and to describe how a dietary intervention with Omega-3 fatty acids affects these changes (objective 2). The occurrence of respiratory infections on the progeny will be analysed, as well as its development and the impact on gut microbiota and epigenetic changes (objective 3). The involvement of breast milk on the neonate's microbiota (sub-objective 1) and epigenetic variations (sub-objective 2) will be depicted. In addition, the direct engagement of milk neutrophils in the ability of the progeny to react against lung infections will be studied (sub-objective 3).

To attain these mother milk and blood samples will be obtained from three groups of lactating mothers: control, obesity or gestational diabetes, upon a dietary intervention with Omega-3 fatty acids. Neutrophil populations of maternal blood and milk samples will be studied by flow cytometry and in vitro assays. The microbiome and miRNA content of infant's saliva and tool samples will be characterized by 16s rRNA gene sequencing and PCR. The occurrence of respiratory infections and the development the infants participating in the study will be tracked during the first 2 years of life by telephone surveys.

To study the impact of the presented maternal variables on the progeny upon a respiratory inflammation on a systemic level, mouse models will be employed. The offspring of lactating dams with gestational diabetes or obesity will be subjected to an artificial acute lung infection. The progression of the lung disease will be studied by histology and the neutrophil profile in the organs of the litter by flow cytometry. The response to acute lung injury after fecal transplantation with infant's microbiota intro germ-free mice as well as of wild type pups breastfeed by neutropenic dams will complement the animal studies.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

IBIMA-Plataforma Bionand

Málaga, Malaga, 29590, Spain

Location status: Recruiting

Location contact

Gloria Luque

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • full term pregnancy (>37 weeks)
  • mother age 18-50 years
  • intention to practice exclusive breastfeeding for at least 3 months

Exclusion criteria

  • preterm pregnancy (<37 weeks)
  • multiple delivery
  • delivery complications that compromise the well-being of the newborn
  • congenital abnormalities of the baby
  • pathologies of the mother such as hypertension, HELLP syndrome, thyroids alterations or nephropathies - drugs or alcohol abuse record
  • occurrence of mastitis during the study
  • mothers practicing tandem nursing

Treatment and study plan

Omega-3 Fatty Acids (EPA plus DHA)

Dietary Supplement

Dietary supplementation with Omega-3 Fatty Acids to study the effect on the immune system of breast milk

Placebo

Dietary Supplement

Inert dietary supplement, without activity in the activation of the immune system of breast milk

Primary outcomes

  1. Characterization of milk neutrophils from three groups of lactating mothers: control or gestational diabetes.

    Time frame: From enrollment to end of treatment at 3 months

  2. Characterization of microbiota and miRNA content of breast milk

    Time frame: From enrollment to end of treatment at 3 months

Study contacts

Contact information is provided by the study sponsor or research team.

Almudena Ortega-Gomez

CONTACT

[email protected]

+34 952367600

Sponsors and collaborators

Lead sponsor

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Other

Registry information

Official study title

The Role of Breast Milk Neutrophils From Mothers With Metabolic Diseases and Impact on Infant Development and Response to Pulmonary Infections

Acronym: PI2222/01813

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Feb 18, 2025
Registry last updated
Feb 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.